跳至主要内容
临床试验/CTRI/2023/05/052160
CTRI/2023/05/052160已完成3 期

A Randomized, Multi-Centric, Open Label, Comparative, Clinical Study To Evaluate The Efficacy and Safety Of Trumove Gel In Patients with Musculo-Skeletal and Joint Pain

Tirupati Pharma, India0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients of either sex aged above 18 years.
  • 2. Patients who are able to understand written and/or verbal instructions and are ready to comply with all study requirements with a willingness to participate and give written informed consent voluntarily.
  • 3. Patients who had been diagnosed with acute and chronic localized musculoskeletal pain and joint pain (arthritis) .

排除标准

  • 1. Women of child bearing potential who are either unwilling or
  • unable to use an acceptable method of birth control to avoid
  • pregnancy during the study period.
  • 2. Subject with active skin lesions or other skin diseases.
  • 3. Subject with history of uncontrolled diabetes
  • 4. Subject with history of Periarthritis, rheumatoid arthritis
  • 5. Known allergy to compounds of investigational product.
  • 6. Participation in an investigational drug trial in the30 days
  • prior to the screeningvisit.
  • 7. Patients of vulnerable group (children, lactating mother, elderly
  • >80 years,handicapped, seriously ill, mentally challenged).
  • 8. History of drug or alcohol abuse during the last 6 months.

研究者

发起方
Tirupati Pharma, India

相似试验